<:HOME:>
About MOASC
Membership
Legislation
Medicare
Community
Employment
Calendar of Events
For Our Members
MOASC Board of Directors

Search

www moasc

Contact Information

Medical Oncology Association of Southern California
P.O. Box 161
Upland, CA 91785
Phone: (909) 985-9061
Fax: (909) 985-8581
email: moasc@moasc.org


MOASC Sponsors

MOASC would like to recognize and thank the following sponsors for their continued support of MOASC:









Your Representatives
Click on the links below to locate contact information for members of Congress:
US Representatives
US Senators


Updated Dec. 11, 2006

House Passes Medicare Bill

December 8, 2006

Moments ago, the House of Representatives passed legislation that would forestall the 5.0% reduction in physician payments that had been scheduled to go into effect in January, 2007.  The Senate is expected to vote on and pass this bill this weekend.  This is an important action that Congress is taking in the last days of the session of the 109th Congress and ASCO and others in the medical community have been actively involved advocating for this legislative fix. 

The legislation would freeze physician payment rates for 2007. In addition, it would tie an increase of 1.5% to reporting of quality measures through the CMS Physician Voluntary Reporting Program (PVRP). Reporting will begin in July 2007. Through our quality programs, ASCO volunteers and staff have developed measures that will position the oncology community to take advantage of any benefits in this bill. ASCO has concerns about the quality reporting provisions in the legislation and will be working with Congress and CMS to achieve a smooth implementation of this law.

Congress did not act on two important issues:

  • Congress did not address the ongoing issue of “underwater drugs” –  those that practices cannot purchase for the Medicare payment rate. ASCO has been working diligently with leaders in Congress to advance a bill introduced by Ralph Hall (R-TX) that would address this issue.  We will continue to educate members and leadership about this problem and work toward a resolution in the 110th Congress. 
  • Congress did not act to avert the reductions in imaging payments that will become effective in 2007. ASCO, working with the Advanced Medical Imaging Coalition (AMIC), has been advocating in the 109th Congress for legislation to delay those cuts, which in some cases are up to 50%.   We will continue to work to delay or ameliorate those cuts in the next Congress.

Other provisions in the bill include: 

  • A provision that would require reporting of hemoglobin or hematocrit levels on any claim for treatment of anemia in connection with cancer treatment effective January 1, 2008.
  • Establishment of a post payment review process for the Competitive Acquisition Program (CAP) to assure that payment is made only if the drug is administered to a beneficiary. 
  • Creation of a Physician Assistance and Quality Initiative Fund to be available for physician payment and quality improvement initiatives in future years. 
  • Expansion of the Recovery Audit Contractor (RAC) program in which Medicare overpayments are identified to all 50 states.

ASCO is analyzing this very complex piece of legislation and is preparing an analysis of all of the provisions of this bill and those that Congress did not address. Please contact ASCO’s Cancer Policy and Clinical Affairs Department with any questions at 703-299-1050 or publicpolicy@asco.org

[POSTED 12/11/06]

Hoag Cancer Center CME Conference

Cancer 2007 Preferred Treatment and Management Options
February 8 – 10, 2007

Learn which treatments are preferred by colleagues from throughout the United States and understand the rationale for preferred treatment options as perceived by national experts.

Download brochure >>

[POSTED 12/08/06]


Mark Your Calendar for

"Highlights of ASH
"

February 9 -10, 2007
The Ritz Carlton
Marina Del Rey, CA

Geared toward practitioners, fellows, and academicians the second annual Highlights of ASH is the only “Highlights” meeting that is produced by ASH. Make your plans to attend the Highlights of ASH in February to hear expert analysis of the top abstracts of 2006, discuss real cases with leaders in the field, and network with colleagues while earning category 1 CME credits. The educational program will focus on significant advances with clinical importance and ground-breaking research from the 2006 annual meeting.

Registration is now open.

This meeting is produced by ASH and presented in conjunction with the Association of Northern California Oncologists (ANCO) and the Medical Oncology Association of Southern California (MOASC).

Download the event brochure for more details.

 

Herceptin (Trastuzumab), has received new FDA approval as part of a treatment regimen containing doxorubicin, cyclophosphamide, and paclitaxel, is indicated for the adjuvant treatment of patients with HER2‑overexpressing, node positive breast cancer. (See the Herceptin website for further details.) Read the FDA approval letter here.

[POSTED 12/11/06]

Dacogen (Decitabine IV) has been assigned a new HCPCS J- code, J0894 by CMS effective January 1, 2007.  The billing unit for this code is 1 mg. and Dacogen is supplied in a 50 mg. single dose vial.  The J0894 Dacogen code is to be used in the physician office and hospital settings.

Dacogen is indicated for the treatment of patients with myelodysplastic syndromes (MDS), including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes ( RA, RARS, RAEB, RAEB-t, CMML ) and Intermediate-1, Intermediate-2, and High-Risk International Prognostic Scoring System (IPSS) groups.

[POSTED 12/04/06]

On September 27, 2006, the FDA approved Vectibix™ (panitumumab) following priority review.  Vectibix™ is the first entirely human monoclonal antibody for the treatment of patients with epidermal growth factor receptor (EGFr) expressing metastatic colorectal cancer after disease progression on, or following fluoropyrimidine, oxaliplatin and irinotecan containing chemotherapy regimens. 

 Vectibix™ is administered by I.V. infusion (over 60 minutes) incident to a physician's service.:

·          Vectibix™ (panitumumab) FDA approval letter           

·          Vectibix™ (panitumumab) FDA approved package insert

·          The Amgen press release as a word document and the link:   http://www-ext.amgen.com/media/media_pr_detail.jsp?releaseID=909842

As stated in the press release, Vectibix™ should be commercially available by October 13th.



CMS offers Billing Guide

The new 2006 Flu Billing Guide is available for download.

Flu season is here! Medicare patients give many reasons for not getting their flu shot, including—“It causes the flu; I don’t need it; it has side effects; it’s not effective; I didn’t think about it; I don’t like needles!”  The fact is that out of the average 36,000 people in the U.S. who die each year from influenza and complications of the virus, greater than 90 percent of deaths occur in persons 65 years of age and older. You can help your Medicare patients overcome these odds and their personal barriers through patient education. Talk to your Medicare patients about the importance of getting their annual flu shot--and don’t forget to immunize yourself and your staff. Protect yourself, your patients, and your family and friends. Get Your Flu Shot. Remember - Influenza vaccination is a covered Part B benefit.  Note that influenza vaccine is NOT a Part D covered drug. For more information about Medicare’s coverage of adult immunizations and educational resources, go to CMS’s website:  http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0667.pdf . (CMS Message 200611-01)



2006 ASP Drug Pricing Files


http://www.cms.hhs.gov/McrPartBDrugAvgSalesPrice/02_aspfiles.asp#TopOfPa

Medicare Part B for 2007 For CY 2007

The following rates are applicable for Medicare Part B Deductible and Coinsurance:
Deductible $131.00 per year
Coinsurance 20 percent

November

November 16, 2006

  • REMINDER: The physician election period for the 2007 Medicare CAP will conclude on November 15. 

    The physician election period for the 2007 Medicare Part B Drug Competitive Acquisition Program (CAP) will conclude on November 15, 2006. Completed and signed physician election forms should be returned by mail to your local carrier. Forms must be postmarked on or before November 15, 2006.  The CAP is an alternative to the Average Sales Price (ASP) method of acquiring many drugs and biologicals administered incident to a physician’s services.

    Additional information about the CAP is available at http://www.cms.hhs.gov/CompetitiveAcquisforBios/01_overview.asp .

    Additional information about the 2007 CAP physician election process is at http://www.cms.hhs.gov/CompetitiveAcquisforBios/02_infophys.asp .

    The list of drugs supplied by the CAP vendor, including NDCs, is in the Downloads section at http://www.cms.hhs.gov/CompetitiveAcquisforBios/15_Approved_Vendor.asp .

    CAP physician election is an annual process that provides an opportunity for physicians who are not participating in the CAP to join. Physicians who are currently participating in the CAP must submit an election form in order to continue participation or to terminate participation. Physicians who are not participating in the CAP and do not wish to participate in the CAP at this time are not required to take any action.  (CMS Message 200611-07) 
  • Effective at the earliest, July 1, 2007, the carrier standard system for Medicare will automatically process all diagnosis codes you submit on your claims.  Read more about it in the MLN Matters Article titled "Processing All Diagnosis Codes Reported on Claims Submitted to Carriers" (CR 4276).
  • The article on Top 10 Claims submission errors has been updated.
  • Please review this new information on Appeals with a new address for the second level of appeal known as a Reconsideration.
  • The Independent Diagnostic Testing Facility - Revised  LCD for California has been finalized and will be on the CMS web site on Thursday 11/16/06, under the future LCD index.  This LCD will become effective 1/1/2007. 
  • CMS Article Numbering System for LCDs
    Effective November 16, 2006, a new numbering system will be used for the CMS LCD Article database.  The  “Article ID Number”, assigned by the CMS Medicare Article Database, will be uniform across California.

November 09, 2006

November 07, 2006

  • Medicare Part B Drug Competitive Acquisition Program (CAP): Physician election period for 2007 ends on November 15, 2006 All physicians and physician groups who wish to participate in the CAP during 2007 must submit a signed and completed Physician Election Agreement Form by mail to their local carrier. The form must be postmarked on or before November 15, 2006.

    This fall’s CAP physician election process provides an opportunity for physicians to join the CAP for 2007. Physicians must elect to participate in the CAP program annually; therefore physicians currently participating in the CAP must go through the election process in order to affirm their participation for 2007 or to leave the program at the end of 2006. Please note that physicians who are currently not participating in the CAP and who do not want to participate in the CAP are not required to fill out the Physician Election Agreement form or to take any other action.

    The CAP is an alternative to the Average Sales Price (ASP or “buy and bill”) system of acquiring certain drugs that are commonly administered incident to a physician’s services. Additional information about the CAP physician election process for 2007 may be found at the following CMS website http://www.cms.hhs.gov/CompetitiveAcquisforBios/02_infophys.asp#TopOfPage (JSM 07053)

November 02, 2006


October

October 26, 2006

October 19, 2006

  • Guide to 2007 Medicare Part B Drug Competitive Acquisition Program (CAP) Physician Election Process. (JSM 06703)
  • New listserv for physicians participating in the Medicare Part B Drug Competitive Acquisition Program (CAP). (CMS Message 200610-09)
  • A reminder about Medicare Preventive Services provider education products. (CMS Message 200610-10)
  • Effective October 18, 2006 the Medicare interest rate for overpayments and underpayments has been changed to 12.375 percent. Historical Data available . (CR 5297)
  • The article on the revised Form CMS-1500, which accommodates the reporting of the National Provider Identifier (NPI), has been revised. (CR 5060)
  • CMS publishes The Quarterly Provider Update on the first business day of each quarter. It is a listing of all non-regulatory changes to Medicare including Program Memoranda, manual changes, and any other instructions that could affect providers.
  • CMS will be administering the 2007 Medicare Contractor Provider Satisfaction Survey (MCPSS) beginning in January 2007. The MCPSS is designed to measure provider satisfaction with and perceptions about the services provided to Medicare providers and suppliers. All FIs, RHHIs, Carriers, DMERCs, DME MACs and the A/B MAC will be included as Fee-for-Service (FFS) Contractors in the national administration of the survey. (JSM 07009)
  • The Newsletter pages have been revised to make it easier to locate current and archived editions.
  • The following LCDs were revised due to the annual ICD-9 CM update, effective 10/1/2006: Allergy Testing; Cardiovascular Nuclear Medicine; Cardiovascular Stress Testing; Echocardiography, Transthoracic and Transesophageal - Revised;  ECG (Electrocardiograms); Erythropoietin Analog; Flow Cytometry; MRA of the Abdomen, Pelvis and Chest; IVIG - Intravenous Immune Globulin; Pulmonary Function Testing -Revised; Radiologic Exam, Chest; and Vestibular Function Testing. All of these can be accessed from the NHIC Active LCD Index on the CMS Website:

    NHIC, Corp. – Northern California – 31140

    NHIC, Corp. – Southern California – 31146

  • The Questions and Answers from the National Provider Identifier (NPI) ACT have been posted.
  • New quarterly Customer Service FAQs have been added.

October 12, 2006

October 05, 2006


MOASC 2006 Drug Grid

MOASC Calendar

The MOASC calendar is now available online!

Please log onto the MOASC weboffice site so you can see the calendar all the way through 2008. The URL is: http://moasccalendar.
webexone.com


Contact the MOASC office for log-in information.


MOASC Marketplace
Position: Oncologist seeking California Read More>>


Article Index & Archives

To access previous updates, please choose from the date of publication below:

Click here to access the Homepage Archive Index



Link Library

Drug Updates & Hotlines

Partnership For Prescriptions Assistance lists all major pharmaceutical companies and their contact information for patient assistance programs.

Drug Reimbursement & Support Programs Hotlines


MOASC Member Directory
The 2006-2007 MOASC Membership Directory is available for download.